These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 16332988

  • 1. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
    Ohtani M, Oka T, Badyuk M, Xiao Y, Kellar KJ, Daly JW.
    Mol Pharmacol; 2006 Mar; 69(3):899-907. PubMed ID: 16332988
    [Abstract] [Full Text] [Related]

  • 2. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI.
    Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345
    [Abstract] [Full Text] [Related]

  • 4. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
    Xiao Y, Meyer EL, Thompson JM, Surin A, Wroblewski J, Kellar KJ.
    Mol Pharmacol; 1998 Aug 14; 54(2):322-33. PubMed ID: 9687574
    [Abstract] [Full Text] [Related]

  • 5. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec 14; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 6. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB, McMahon LR.
    Psychopharmacology (Berl); 2017 Mar 14; 234(5):781-792. PubMed ID: 28028600
    [Abstract] [Full Text] [Related]

  • 7. Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H]5-HT from rat hippocampal slices.
    Lendvai B, Sershen H, Lajtha A, Santha E, Baranyi M, Vizi ES.
    Neuropharmacology; 1996 Mar 14; 35(12):1769-77. PubMed ID: 9076756
    [Abstract] [Full Text] [Related]

  • 8. Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture.
    Gallardo KA, Leslie FM.
    J Neurochem; 1998 Feb 14; 70(2):663-70. PubMed ID: 9453560
    [Abstract] [Full Text] [Related]

  • 9. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, St John PA, Lukas RJ.
    J Physiol; 2006 Oct 01; 576(Pt 1):103-18. PubMed ID: 16825297
    [Abstract] [Full Text] [Related]

  • 10. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ, Meinerz NM, Drago J, Collins AC.
    Neuropharmacology; 2007 Sep 01; 53(3):390-405. PubMed ID: 17631923
    [Abstract] [Full Text] [Related]

  • 11. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ, Whiteaker P, Collins AC.
    Mol Pharmacol; 2006 Sep 01; 70(3):947-59. PubMed ID: 16728647
    [Abstract] [Full Text] [Related]

  • 12. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.
    Stauderman KA, Mahaffy LS, Akong M, Veliçelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM, Corey-Naeve J.
    J Pharmacol Exp Ther; 1998 Feb 01; 284(2):777-89. PubMed ID: 9454827
    [Abstract] [Full Text] [Related]

  • 13. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.
    J Pharmacol Exp Ther; 1998 May 01; 285(2):777-86. PubMed ID: 9580626
    [Abstract] [Full Text] [Related]

  • 14. Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum.
    Puttfarcken PS, Jacobs I, Faltynek CR.
    Neuropharmacology; 2000 Oct 01; 39(13):2673-80. PubMed ID: 11044737
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
    Avila AM, Dávila-García MI, Ascarrunz VS, Xiao Y, Kellar KJ.
    Mol Pharmacol; 2003 Oct 01; 64(4):974-86. PubMed ID: 14500754
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE, Loetz EC, Marks MJ.
    Pharmacol Biochem Behav; 2015 Mar 01; 130():1-8. PubMed ID: 25560939
    [Abstract] [Full Text] [Related]

  • 17. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P, Sharples CG, Wonnacott S.
    Mol Pharmacol; 1998 May 01; 53(5):950-62. PubMed ID: 9584223
    [Abstract] [Full Text] [Related]

  • 18. Nicotinic receptor agonist-induced salivation and its cellular mechanism in parotid acini of rats.
    Iida T, Ono K, Inagaki T, Hosokawa R, Inenaga K.
    Auton Neurosci; 2011 Apr 26; 161(1-2):81-6. PubMed ID: 21300575
    [Abstract] [Full Text] [Related]

  • 19. Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors.
    Michelmore S, Croskery K, Nozulak J, Hoyer D, Longato R, Weber A, Bouhelal R, Feuerbach D.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep 26; 366(3):235-45. PubMed ID: 12172706
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
    Ridley DL, Rogers A, Wonnacott S.
    Br J Pharmacol; 2001 Aug 26; 133(8):1286-95. PubMed ID: 11498514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.